Novo Nordisk to work with Anthropic on drug development

Novo Nordisk will work with Anthropic to speed drug development using AI, a strategic move as Novo seeks to catch up in the competitive obesity market.

• Anthropic Tests Claude Money Banking Feature2026-09-17
• UW professor: AI extinction unlikely2026-09-17
• Security experts urge basics before external AI audits2026-09-17
• Anthropic: adversaries used AI to target US naval forces2026-09-16
• Anthropic warns industry can't rely on an 'honor code'2026-09-16